Senior Scientist
Listed on 2026-10-11
-
Research/Development
Research Scientist, Immunology Research
Irazu Oncology is a preclinical biotechnology company based in Baltimore, Maryland developing its cancer immunotherapy platform. Irazu offers a dynamic and entrepreneurial environment where employees can grow and develop both personally and professionally. The company is seeking a skilled, passionate and motivated scientist to assist with research and development. The company is located in the 4
MLK building at the UMB Biopark in Baltimore.
Reporting to the Director of Research, the Senior Scientist will design, execute, analyze, and interpret experiments to advance Irazu Oncology’s proprietary OMV-based cancer immunotherapy platform. This role will contribute to our lead drug program and support future pipeline candidates and beyond. We are looking for a collaborative team player with hands-on experience in molecular biology (primer design, PCR, and qPCR), protein-fusion and linker design, antibody-based assays, bacterial culture (ideally Gram-negative bacteria), and in vivo mouse work.
The ideal candidate is proactive, enjoys a fastpaced startup setting, and can take experiments from design through data interpretation.
- Ph.D. in Molecular Biology, Microbiology, Immunology, or a related field with 2-3+ years of relevant experience; or M.S. with 4–7+ years; or B.S. with 7+ years.
- Hands-on primer design, PCR, and qPCR.
- Experience designing protein fusions, including linker sequences and peptide-tag copy number.
- Hands-on antibody-based assays, including Western blot and ELISA.
- Hands-on in vivo mouse experience, including dosing and/or tissue harvest.
- Hands-on experience with molecular cloning, bacterial culture, or cell culture techniques.
- High level of initiative, motivation, and willingness to work in a fast-paced environment.
- Excellent communication skills, with the ability to present research at intra- and interdepartmental meetings.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).